TF and cancer: Increased plasmatic levels of EVs, and especially of pro-coagulant tissue factor (TF) bearing EVs, are characteristic of various cancers and have been shown to be involved in metastasis and the development of DVT in cancer patients (Tesselaar et al., 2007; Tesselaar et al., 2009; Manly et al., 2010).